An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 Infection

EPICC COVID-19 Cohort Study Group, Ann I Scher, Catherine M Berjohn, Celia Byrne, Rhonda E Colombo, Christopher J Colombo, Margaret Sanchez Edwards, Evan C Ewers, Anuradha Ganesan, Milissa Jones, Derek T Larson, Daniel Libraty, David A Lindholm, Cristian S Madar, Carlos J Maldonado, Ryan C Maves, Katrin Mende, Stephanie A Richard, Julia S Rozman, Jennifer RusieckiAlfred Smith, Mark Simons, David Tribble, Brian Agan, Timothy H Burgess, Simon D Pollett

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 Infection'. Together they form a unique fingerprint.

Medicine & Life Sciences